ITI-214

Overview

ITI-214 is under investigation in clinical trial NCT03489772 (Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement).

ITI-214 is under investigation in clinical trial NCT03489772 (Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement).

No indication information available.

No associated conditions information available.

Title	Posted	Study ID	Phase	Status	Sponsor
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease	2023/03/13	NCT05766813	Phase 2	Recruiting	Intra-Cellular Therapies, Inc.
Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement	2018/04/05	NCT03489772	Phase 1	Completed	Intra-Cellular Therapies, Inc.
Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure	2018/01/02	NCT03387215	Phase 1	Completed	Intra-Cellular Therapies, Inc.
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease	2017/08/22	NCT03257046	Phase 1	Completed	Intra-Cellular Therapies, Inc.
Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia	2013/07/16	NCT01900522	Phase 1	Terminated	Takeda

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

No news found